{"id":"https://openalex.org/W2047448682","doi":"https://doi.org/10.2165/00019053-199712050-00008","title":"Cost-Benefit Analysis of Riluzole for the Treatment of Amyotrophic Lateral Sclerosis","display_name":"Cost-Benefit Analysis of Riluzole for the Treatment of Amyotrophic Lateral Sclerosis","publication_year":1997,"publication_date":"1997-11-01","ids":{"openalex":"https://openalex.org/W2047448682","doi":"https://doi.org/10.2165/00019053-199712050-00008","mag":"2047448682","pmid":"https://pubmed.ncbi.nlm.nih.gov/10174324"},"language":"en","primary_location":{"id":"doi:10.2165/00019053-199712050-00008","doi":"https://doi.org/10.2165/00019053-199712050-00008","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00019053-199712050-00008","pdf_url":null,"source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035525498","display_name":"Gary Michael Ginsberg","orcid":"https://orcid.org/0000-0001-6756-1900","observed_orcids":["https://orcid.org/0000-0001-6756-1900","https://orcid.org/0000-0003-1315-890X"]},"institutions":[{"id":"https://openalex.org/I2802540905","display_name":"Israel Ministry of Health","ror":"https://ror.org/016n0q862","country_code":"IL","type":"government","lineage":["https://openalex.org/I2802540905"]}],"countries":["IL"],"is_corresponding":true,"raw_author_name":"Gary M. Ginsberg","raw_affiliation_strings":["Department of Medical Technology Assessment, Ministry of Health, Jerusalem, Israel. mttgary@matat.health.gov.il","Ministry of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Technology Assessment, Ministry of Health, Jerusalem, Israel. mttgary@matat.health.gov.il","institution_ids":["https://openalex.org/I2802540905"]},{"raw_affiliation_string":"Ministry of Health","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111875412","display_name":"Boaz I. Lev","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802540905","display_name":"Israel Ministry of Health","ror":"https://ror.org/016n0q862","country_code":"IL","type":"government","lineage":["https://openalex.org/I2802540905"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Boaz Lev","raw_affiliation_strings":["Medical Services Division, Ministry of Health, Jerusalem, Israel","Ministry of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Services Division, Ministry of Health, Jerusalem, Israel","institution_ids":["https://openalex.org/I2802540905"]},{"raw_affiliation_string":"Ministry of Health","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5035525498"],"corresponding_institution_ids":["https://openalex.org/I2802540905"],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":null,"fwci":1.9941,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.86067109,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"12","issue":"5","first_page":"578","last_page":"584"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10855","display_name":"Amyotrophic Lateral Sclerosis Research","score":0.7705000042915344,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10855","display_name":"Amyotrophic Lateral Sclerosis Research","score":0.7705000042915344,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.22579999268054962,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/riluzole","display_name":"riluzole","score":1.0},{"id":"https://openalex.org/keywords/amyotrophic-lateral-sclerosis","display_name":"amyotrophic lateral sclerosis","score":1.0},{"id":"https://openalex.org/keywords/cost-benefit-analysis","display_name":"cost-benefit analysis","score":0.9350000023841858},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.5640000104904175},{"id":"https://openalex.org/keywords/life-expectancy","display_name":"life expectancy","score":0.6380000114440918},{"id":"https://openalex.org/keywords/benefit-cost-ratio","display_name":"benefit-cost ratio","score":0.671999990940094},{"id":"https://openalex.org/keywords/productivity-benefits","display_name":"productivity benefits","score":0.5379999876022339},{"id":"https://openalex.org/keywords/hospitalization-costs","display_name":"hospital costs","score":0.5989999771118164},{"id":"https://openalex.org/keywords/social-benefits","display_name":"social benefits","score":0.34700000286102295}],"concepts":[{"id":"https://openalex.org/C2779319286","wikidata":"https://www.wikidata.org/wiki/Q415744","display_name":"Riluzole","level":4,"score":0.9115704298019409},{"id":"https://openalex.org/C2780596555","wikidata":"https://www.wikidata.org/wiki/Q206901","display_name":"Amyotrophic lateral sclerosis","level":3,"score":0.9024810791015625},{"id":"https://openalex.org/C2778091340","wikidata":"https://www.wikidata.org/wiki/Q15749950","display_name":"Quality of Life Research","level":3,"score":0.6615979671478271},{"id":"https://openalex.org/C524218345","wikidata":"https://www.wikidata.org/wiki/Q31218","display_name":"Health economics","level":3,"score":0.6373235583305359},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5188301801681519},{"id":"https://openalex.org/C2776738588","wikidata":"https://www.wikidata.org/wiki/Q1567856","display_name":"Pharmacoeconomics","level":2,"score":0.43780940771102905},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.40956276655197144},{"id":"https://openalex.org/C99508421","wikidata":"https://www.wikidata.org/wiki/Q2678675","display_name":"Physical medicine and rehabilitation","level":1,"score":0.34596943855285645},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3408289849758148},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.17119932174682617},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15589606761932373},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.11013972759246826}],"mesh":[{"descriptor_ui":"D000690","descriptor_name":"Amyotrophic Lateral Sclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012680","descriptor_name":"Sensitivity and Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017048","descriptor_name":"Health Care Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019782","descriptor_name":"Riluzole","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2165/00019053-199712050-00008","doi":"https://doi.org/10.2165/00019053-199712050-00008","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00019053-199712050-00008","pdf_url":null,"source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},{"id":"pmid:10174324","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10174324","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W38677234","https://openalex.org/W92741982","https://openalex.org/W186168098","https://openalex.org/W1506357578","https://openalex.org/W1968042426","https://openalex.org/W1968533747","https://openalex.org/W1969562170","https://openalex.org/W1989533240","https://openalex.org/W1992573335","https://openalex.org/W2008177239","https://openalex.org/W2038226090","https://openalex.org/W2046478987","https://openalex.org/W2047288163","https://openalex.org/W2054490488","https://openalex.org/W2064951237","https://openalex.org/W2065353775","https://openalex.org/W2074714116","https://openalex.org/W2083067786","https://openalex.org/W2085165928","https://openalex.org/W2143036043","https://openalex.org/W2314689571","https://openalex.org/W2402657290","https://openalex.org/W2464045078","https://openalex.org/W2479268747"],"related_works":["https://openalex.org/W2078528420","https://openalex.org/W2049712333","https://openalex.org/W1966677115","https://openalex.org/W1557394241","https://openalex.org/W4409048793","https://openalex.org/W1984828211","https://openalex.org/W3091919732","https://openalex.org/W2798585275","https://openalex.org/W2686176395","https://openalex.org/W3028568472"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}